
IHC-P analysis of human breast carcinoma tissue using GTX50207 JAK1 (phospho Tyr1022) antibody. Left : Primary antibody Right : Primary antibody pre-incubated with the antigen specific peptide
JAK1 (phospho Tyr1022) antibody

GTX50207
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetJAK1
Overview
- SupplierGeneTex
- Product NameJAK1 (phospho Tyr1022) antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:1000. IHC-P: 1:50-1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID3716
- Target nameJAK1
- Target descriptionJanus kinase 1
- Target synonymsAIIDE; JAK1A; JAK1B; JTK3; tyrosine-protein kinase JAK1
- HostRabbit
- IsotypeIgG
- Modification TypePhosphorylated
- Protein IDP23458
- Protein NameTyrosine-protein kinase JAK1
- Scientific DescriptionThis gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta and interferon-gamma signal transduction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA. Wu R et al., 2020 Nov, J Immunother CancerRead more